Program

[Chairperson’s Special Session] February 14, 2020

Current problems on the risk communication

  • Kazuya Nakayachi, Doshisha University, Japan
  • Fumitaka Shibata, Tokyo University of Agriculture, Japan

[Special Session 1] February 13, 2020

Risk assessment of regenerative medicine

  • Shin Kawamata, Foundation for Biomedical Research and Innovation, Japan
  • Satoshi Yasuda, National Institute of Health Sciences, Japan

[Special Session 2] February 14, 2020

Hepatotoxicity in the immunotherapy of cancer

  • Timothy W. Affolter, Phizer Inc., USA

[Symposium 1] February 13, 2020

Risk assessment of medical devices

  • Yuji Haishima, National Institute of Health Sciences, Japan
  • Hitomi Hagiwara, Terumo Corporation, Japan
  • Yasushi Miyauchi, Kamakura Techno-Science, Inc., Japan

[Symposium 2] February 14, 2020

Spreading of the wing of JSTP

  • Yong Hyun Jung, DT &CRO, Korea
  • Yasuhiro Tanaka, Suntory MONOZUKURI Expert LTD. / ILSI Japan
  • Klaus Weber, AnaPatbh GmbH and AnaPath Services GmbH, Switzerland

[Symposium 3] February 14, 2020

Modernization of toxicologic pathology

  • Hiroshi Suemizum Central Institute for Experimental Animals, Japan
  • Atsuhiko Kato, Chugai Pharmaceutical Co., Ltd, Japan
  • Katsuhiro, Miyajima, Tokyo University of Agriculture, Japan

[Workshop] February 13, 2020

Forefront of toxicologic pathology

  • Norimitsu Shirai, Pfizer Inc., USA
  • Shunji Nakatsuji, Altasciences Preclinical Seattle LLC, USA
  • Naoaki Yamada, LSI Medience Corporation, Japan
  • Satoshi Furukawa, Nissan Chemical Corporation, Japan

[IATP/JSTP Maronpot Guest Lecture] February 13, 2020

Confounders for kidney carcinogenesis in cancer bioassays

  • Gordon C. Hard, Consultant in Toxicology, Pathology, Carcinogenesis, New Zealand
To top ▲
東京農業大学助成金交付学術集会 ヤクルト中央研究所バナー